Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Carrier

Showing results (271-280 of 421) with videos related to

Pageof 43
Sort By:
Cancer|March 9, 2026
Risks of thrombosis and hemorrhage in concurrent use of anticoagulants and potential interacting prostate cancer agentsTzu-Fei Wang, Anna Clarke, Mitchell Rath, et al.
Plos Medicine|June 22, 2010
The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studiesMarc A Rodger, Marisol T Betancourt, Peter Clark, et al.
Thrombosis and Haemostasis|March 23, 2018
Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort StudySam Schulman, Peter L Gross, Bruce Ritchie, et al.
Urologic Oncology|May 17, 2022
Venous thromboembolism risk in patients receiving neoadjuvant chemotherapy for bladder cancerShady N Garas, Kristen McAlpine, James Ross, et al.
Thrombosis Research|September 13, 2011
Does the Pulmonary Embolism Severity Index accurately identify low risk patients eligible for outpatient treatment?Petra M G Erkens, Esteban Gandara, Philip S Wells, et al.
Thrombosis and Haemostasis|November 13, 2018
Erratum to: Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort StudySam Schulman, Peter L Gross, Bruce Ritchie, et al.
Journal of Thrombosis and Haemostasis : JTH|July 13, 2020
Risk scores for occult cancer in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysisFrits I Mulder, Marc Carrier, Frederiek van Doormaal, et al.
Thrombosis Update|April 15, 2024
Venous thromboembolism risk, prophylaxis and management in cancer patients with COVID-19: An unmet medical needBenjamin Brenner, Cihan Ay, Grégoire Le Gal, et al.
Research and Practice in Thrombosis and Haemostasis|December 14, 2020
Establishing diagnostic criteria and treatment of subsegmental pulmonary embolism: A Delphi analysis of expertsPaul L den Exter, Lucia J M Kroft, Carol Gonsalves, et al.
BMJ Open|January 14, 2021
Clinical Surveillance vs. Anticoagulation For low-risk patiEnts with isolated SubSegmental Pulmonary Embolism: protocol for a multicentre randomised placebo-controlled non-inferiority trial (SAFE-SSPE)Christine Baumgartner, Frederikus A Klok, Marc Carrier, et al.
Pageof 43

Showing results (271-280 of 421) with videos related to

Sort By:
Pageof 43
Cancer|March 9, 2026
Risks of thrombosis and hemorrhage in concurrent use of anticoagulants and potential interacting prostate cancer agentsTzu-Fei Wang, Anna Clarke, Mitchell Rath, et al.
Plos Medicine|June 22, 2010
The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studiesMarc A Rodger, Marisol T Betancourt, Peter Clark, et al.
Thrombosis and Haemostasis|March 23, 2018
Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort StudySam Schulman, Peter L Gross, Bruce Ritchie, et al.
Urologic Oncology|May 17, 2022
Venous thromboembolism risk in patients receiving neoadjuvant chemotherapy for bladder cancerShady N Garas, Kristen McAlpine, James Ross, et al.
Thrombosis Research|September 13, 2011
Does the Pulmonary Embolism Severity Index accurately identify low risk patients eligible for outpatient treatment?Petra M G Erkens, Esteban Gandara, Philip S Wells, et al.
Thrombosis and Haemostasis|November 13, 2018
Erratum to: Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort StudySam Schulman, Peter L Gross, Bruce Ritchie, et al.
Journal of Thrombosis and Haemostasis : JTH|July 13, 2020
Risk scores for occult cancer in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysisFrits I Mulder, Marc Carrier, Frederiek van Doormaal, et al.
Thrombosis Update|April 15, 2024
Venous thromboembolism risk, prophylaxis and management in cancer patients with COVID-19: An unmet medical needBenjamin Brenner, Cihan Ay, Grégoire Le Gal, et al.
Research and Practice in Thrombosis and Haemostasis|December 14, 2020
Establishing diagnostic criteria and treatment of subsegmental pulmonary embolism: A Delphi analysis of expertsPaul L den Exter, Lucia J M Kroft, Carol Gonsalves, et al.
BMJ Open|January 14, 2021
Clinical Surveillance vs. Anticoagulation For low-risk patiEnts with isolated SubSegmental Pulmonary Embolism: protocol for a multicentre randomised placebo-controlled non-inferiority trial (SAFE-SSPE)Christine Baumgartner, Frederikus A Klok, Marc Carrier, et al.
Pageof 43